Dr. Byrd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4000 Cambridge St
Kansas City, KS 66160Phone+1 913-588-3996
Education & Training
University of Kansas (Wichita)Residency, Internal Medicine, 2012 - 2015
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2012
Certifications & Licensure
MO State License 2021 - 2026
KS State License 2018 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage Start of enrollment: 2019 Nov 22
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 4 citationsMulti-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement.Dahniel Sastow, Joshua Tatarian, Yosef J R A Riazat-Kesh, Kyle Farina, Michelle Becker
Leukemia & Lymphoma. 2023-12-01 - 4 citationsOutcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute...Moazzam Shahzad, Ali Hussain, Ezza Tariq, Iqra Anwar, Muhammad S Faisal
Clinical Lymphoma, Myeloma & Leukemia. 2023-03-01 - Cryptococcal Neoformans and Varicella Zoster Meningitis in a Patient With Selective Innate Immunodeficiency: A Case Report.Sophiya Karki, Kenneth P Byrd
Cureus. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
